Evommune, Inc. (EVMN) Revenue History
Annual and quarterly revenue from 2023 to present
EVMN Revenue Over Time (2023–2025)
EVMN Revenue Growth History
2 of 2 years with positive growth- FY2023 revenue growth
- N/A
- FY2024 revenue growth
- +40.0%
- FY2025 revenue growth
- +85.7%
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $0 | — |
| Q3 2025 | $10.0M | — |
| Q2 2025 | $0 | — |
| Q1 2025 | $3.0M | — |
| Q4 2024 | $0 | — |
Multi-year avg. share of annual revenue by fiscal quarter
EVMN Revenue Analysis (2023–2025)
Current Revenue & Growth
As of June 12, 2026, Evommune, Inc. (EVMN) generated trailing twelve-month (TTM) revenue of $13.0 million. The most recent quarter (Q4 2025) recorded $0 in revenue, down 100.0% sequentially.
Historical Growth Trajectory
EVMN's historical revenue data shows various trends over time. Evommune, Inc.'s highest annual revenue of $13.0 million was recorded in 2025, an all-time high.
Peer Comparison
Compared to Healthcare sector peers — including ARDX (+18.2% YoY), and CLDX (-89.2% YoY). Compare EVMN vs ARDX →
EVMN Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
 EVMNCurrent | $13M | - | - | -623.6% | |
 ARDX | $407M | +18.2% | +121.9% | -10.1% | |
 CLDX | $2M | -89.2% | -27.4% | -19160.0% |
EVMN Historical Revenue Data (2023–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $13.0M | +85.7% | $11.6M | 89.3% | $-81,071,000 | -623.6% |
| 2024 | $7.0M | +40.0% | $5.7M | 81.6% | $-70,013,000 | -1000.2% |
| 2023 | $5.0M | - | $4.0M | 80.0% | $-37,850,000 | -757.0% |
What if you invested $1,000 in EVMN back in 2023?
Total return with dividends reinvested · 3+ years of data
Calculate ReturnsHow much would $100/month in EVMN be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs EVMN Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationHow does EVMN stack up against peers?
Compare business quality, growth, and profitability against top sector peers.
Compare NowEVMN — Frequently Asked Questions
Quick answers to the most common questions about buying EVMN stock.
Is EVMN's revenue growth accelerating or slowing?
EVMN TTM revenue: $13M. YoY growth: N/A. 5-year CAGR: N/A.
What is EVMN's revenue history from 2023 to 2026?
Evommune, Inc. (EVMN) revenue history spans 2023 to 2026. TTM revenue as of 2026 is $13M, growing at N/A YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is EVMN's long-term revenue growth rate (CAGR)?
Evommune, Inc.'s 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for EVMN.
Why does EVMN's quarterly revenue fluctuate?
EVMN quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Evommune, Inc.'s revenue data from 2023 to 2026 shows full historical quarterly detail on this page.
How is EVMN's revenue distributed by segment?
EVMN reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does EVMN's revenue compare to industry peers?
Evommune, Inc. (EVMN) with TTM revenue of $13M and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.